Cytomegalovirus antibodies among healthy blood donors at Lagos University Teaching Hospital

South African Medical Journal

Volumn 99, Issue 7, 2009, Pages 528-530

  Akinbami, A A ^a   Akanmu, A S ^a   Adeyemo, T A ^a   Wright, K O ^a   Dada, M O ^a   Dosunmu, A O ^a  

^a LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFECTION RISK; MALE; NIGERIA; NORMAL HUMAN; SEROPREVALENCE; UNIVERSITY HOSPITAL;

EID: 70049108506     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tolpin MD, Stewart JA, Warren D, et al. Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. J Pediatr 1985; 107: 953-956.
2. Bayer WL, Tegtmeier GE. The blood donor: detection and magnitude of cytomegalovirus carrier status and the prevalence of cytomegalovirus antibody. Yale J Biol Med 1976; 49: 5-12.
3. Adler S. Transfusion-associated cytomegalovirus infections. Rev Infect Dis 1983; 5: 977-993.
4. Lentz EB, Dock NL, McMahon CA, Fiesthumel SR, Arnold CB, Lamberson HV. Detection of anti-body of cytomegalovirus-induced early antigens and comparison with four serologic assays and presence of viruria in blood donors. J Clin Microbiol 1988; 26: 133-135.
5. Lamberson HV, McMillan JA, Weiner LB, et al. Screening blood donors for IgM to CMV. J Infect Dis 1988; 157: 820-823.
6. Krech U. Complement fixing antibodies against CMV in different parts of the world. Bull World Health Organ 1973; 49: 103-106.
7. Atul K, Ramachandrum VG. Seroprevalence of cytomegalovirus among voluntary blood donors in Dehli, India. J Health Popul Nutr 2002; 20(4): 348-351.
8. Pal SR, Chitkara NK, Krech V. Seroepidemiology of cytomegalovirus infection in and around Chandigarh. Indian J Med Res 1972; 60: 973-978.
9. Madhavan HN, Prakash K, Agarwal SC. Cytomegalovirus infections in Pondicherry: a serological survey. Indian J Med Res 1974; 62: 297-300.
10. Lamberson HV Jr, McMillan JA, Weiner LB, et al. Prevention of transfusion-associated cytomegaloviral infection in neonates by screening blood donors for IgM to CMV. J Infect Dis 1988; 157: 820-823.
11. Holland PV, Schmitt PJ. Standards for Blood Banks and Transfusion Services. 12th ed. Arlington, VA: Committee on Standards, American Association of Blood Banks, 1987: 30-31.
12. Galea G, Urbaniak SJ. Cytomegalovirus studies on blood donors in north-east Scotland and a review of UK data. Vox Sang 1993; 64: 24-30.
13. Mollison PL. Some unfavorable effects of transfusion. In: Blood Transfusion in Clinical Practice. 6th ed. Oxford: ELBS Blackwell Scientific Publications, 1979: 617-665.
14. Tolpin MD, Stewart JA, Warren D, et al. Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. J Pediatr 1985; 107: 953-956.
15. Beneke JS, Tegtmeier GE, Alter HJ, Luetkemeyer RB, Solomon R, Bayer WL. Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection. J Infect Dis 1984; 150: 883-888.
16. Mc Cullough JJ. Transfusion transmitted disease. In: Transfusion Medicine. New York: McGraw-Hill, 1998: 361-386.